AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) P/E ratio
As of 5 November 2026, AptarGroup, Inc. (ATR) trades at a P/E ratio of 34.6×. Over the past ten years it has ranged from 17.8× (November 2025) to 43.6× (March 2021); the current reading is higher than 86% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 20.4× | (26.53%) |
| FY2024 | 27.8× | (1.79%) |
| FY2023 | 28.3× | (6.27%) |
| FY2022 | 30.2× | (8.00%) |
| FY2021 | 32.8× | (20.36%) |
| FY2020 | 41.2× | 35.87% |
| FY2019 | 30.3× | 0.65% |
| FY2018 | 30.2× | 22.32% |
| FY2017 | 24.6× | 10.38% |
| FY2016 | 22.3× | (1.95%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 29.1× | 30.27% |
| Jun 2026 | 22.4× | 4.85% |
| Mar 2026 | 21.3× | 4.38% |
| Dec 2025 | 20.4× | (2.95%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RGEN Repligen Corporation compare | n/m |
| BAX Baxter International Inc. compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| COO The Cooper Companies, Inc. compare | 21.7× |
| ALGN Align Technology, Inc. compare | 23.1× |
| AVTR Avantor, Inc. compare | 30.3× |
| ATR AptarGroup, Inc. | 34.6× |
| SOLV Solventum Corporation compare | 97.3× |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ATR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement